Similar articles

• Cardiac catecholamine levels and blood pressure after chronic treatment with beta-adrenergic blocking agents.

  Mazurkiewicz-Kwilecki IM, Romagnoli A. Mazurkiewicz-Kwilecki IM, et al. J Pharm Pharmacol. 1970 Mar;22(3):235-7. doi: 10.1111/j.2042-7158.1970.tb08507.x. J Pharm Pharmacol. 1970. PMID: 4399498 No abstract available.
• Effects of beta-adrenoceptor blocking drugs on the chronotropic and inotropic actions of isoprenaline on the acutely denervated dog heart.

  Harry JD, Kappagoda CT, Linden RJ, Snow HM. Harry JD, et al. Br J Pharmacol. 1971 Feb;41(2):387P-389P. Br J Pharmacol. 1971. PMID: 4396704 Free PMC article. No abstract available.
• An experimental study of the beta-receptor blocking agents on the cardiac performance in dogs.

  Singh N, Srivastava RK, Kulshrestha VK, Sinha JN, Kohli RP, Bhargava KP. Singh N, et al. Jpn J Pharmacol. 1970 Dec;20(4):467-72. doi: 10.1254/jjp.20.467. Jpn J Pharmacol. 1970. PMID: 4395619 No abstract available.
• [Cuent pharmacological theory of anti-arrhythmia agents, with special reference to beta-receptor blockaders].

  Takenaka F, Takeya N. Takenaka F, et al. Nihon Rinsho. 1969 Oct;27(10):2470-8. Nihon Rinsho. 1969. PMID: 4390982 Review. Japanese. No abstract available.
• The beta-adrenergic blocking agents pharmacology and structure-activity relationships.

  Biel JH, Lum BK. Biel JH, et al. Fortschr Arzneimittelforsch. 1966;10:46-89. doi: 10.1007/978-3-0348-7059-7_3. Fortschr Arzneimittelforsch. 1966. PMID: 4860334 Review. No abstract available.